Dorsomorphin (Compound C): Precision AMPK & BMP Inhibition in Translational Research

Introduction: Principle and Setup of Dorsomorphin (Compound C)

Dorsomorphin, also known as Compound C, is a cornerstone tool in translational biology for dissecting the crosstalk between metabolic regulation and cellular differentiation. As a cell-permeable, reversible, and ATP-competitive AMPK inhibitor (Ki = 109 nM), Dorsomorphin selectively targets AMP-activated protein kinase activity, exerting minimal off-target effects on closely related kinases such as PKA, PKC, and JAK3. Its unique dual-action also extends to potent inhibition of the BMP/Smad signaling pathway, positioning it at the nexus of metabolic, autophagy, and developmental research.

Dorsomorphin’s mechanistic versatility is especially valuable for studies probing autophagy regulation, BMP4-induced SMAD phosphorylation inhibition, neural stem cell differentiation, and iron metabolism modulation. Its performance profile—such as 80% inhibition of acetyl-CoA carboxylase (ACC) phosphorylation and robust suppression of autophagic proteolysis—enables quantitative interrogation of the AMPK signaling pathway in both in vitro and in vivo systems.

For a comprehensive product overview, including structure, storage, and solubility details, visit the official Dorsomorphin (Compound C) product page.

Step-by-Step Workflow: Optimized Experimental Protocols

Preparation and Solubilization

• Solubility: Dorsomorphin is insoluble in water or ethanol. Dissolve the compound in DMSO at concentrations ≥8.49 mg/mL. Use gentle warming and ultrasonic agitation to ensure homogeneity.
• Storage: Store Dorsomorphin as a solid at -20°C. Prepare working solutions immediately before use, as long-term storage of solutions is not recommended due to potential degradation.

In Vitro Applications

1. Cell Culture Preparation: Seed hepatocytes, HeLa cells, or neural stem cells as per standard protocols. Allow for optimal attachment and confluency (typically 60–80%).
2. Treatment: Add Dorsomorphin in DMSO directly to the culture medium to reach desired final concentrations (4–40 μM). Maintain DMSO concentration <0.1% v/v to avoid cytotoxicity.
3. Incubation: Common exposure times range from 1 to 24 hours, depending on the readout (e.g., AMPK phosphorylation, SMAD1/5/8 activity, autophagy flux).
4. Readouts: Quantify inhibition of AMPK activity via Western blotting for p-ACC or use phospho-specific antibodies for BMP/Smad pathway interrogation. Assess autophagic flux with LC3-II/I ratio and p62/SQSTM1 degradation.

In Vivo Applications

1. Animal Model Selection: Dorsomorphin is widely used in murine models to probe iron metabolism modulation and skeletal muscle atrophy.
2. Dosing: Administer intraperitoneally at 10 mg/kg. Prepare freshly prior to injection.
3. Endpoint Analysis: Evaluate hepatic hepcidin mRNA, serum iron levels, and downstream phosphorylation events (e.g., ACC, SMAD1/5/8).

For detailed strategy and advanced workflow considerations, the article "Dorsomorphin (Compound C): Strategic Deployment of Dual-Pathway Inhibition" offers an in-depth complement, particularly surrounding translational disease models.

Advanced Applications and Comparative Advantages

Muscle Atrophy and Metabolic Syndrome Modeling

Dorsomorphin’s robust inhibition of AMPK makes it indispensable for dissecting the AMPK/PINK1/Parkin axis in mitophagy and muscle health. For instance, in studies examining sarcopenic obesity, such as Ren et al. (2025), Dorsomorphin was used to block AMPK activity, thereby negating the beneficial effects of Lycium barbarum polysaccharide (LBP) on skeletal muscle mitochondrial function. This direct evidence demonstrates how Dorsomorphin enables causal inference in metabolic and autophagy regulation, confirming that AMPK activation is essential for LBP-mediated mitophagy and muscle preservation.

Quantitative highlights include:

• Near-complete inhibition of ACC phosphorylation (>80%) at 10–40 μM in cell culture.
• Suppression of autophagic proteolysis and modulation of the LC3II/I ratio in muscle cells.
• Inhibition of BMP4-induced SMAD1/5/8 phosphorylation with an IC₅₀ of 0.47 μM.

Neural Induction and Stem Cell Engineering

Dorsomorphin’s capacity as a BMP signaling inhibitor is pivotal in promoting neural differentiation and self-renewal in human embryonic stem cells. By blocking BMP-driven SMAD phosphorylation, Dorsomorphin channels pluripotent cells towards a neural lineage—a strategy validated in both basic neuroscience and regenerative medicine research.

Cancer Research and Iron Metabolism

The dual modulation of AMPK and BMP/Smad pathways by Dorsomorphin is increasingly leveraged in cancer research, where metabolic reprogramming and autophagy intersect with oncogenic signaling. In hepatic models, Dorsomorphin reduces hepcidin gene transcription, resulting in increased serum iron levels—a key parameter in studies of tumor metabolism and systemic iron homeostasis.

For a comparative angle, the article "Strategic Dual-Pathway Inhibition: Advancing Translational Research with Dorsomorphin" extends these insights by providing mechanistic contrasts between Dorsomorphin and other pathway inhibitors, highlighting its unique selectivity and translational potential.

Troubleshooting & Optimization Tips

• Solubility Issues: If Dorsomorphin does not dissolve fully in DMSO, warm gently (≤37°C) and sonicate. Avoid using water or ethanol as solvents.
• Compound Stability: Prepare working solutions immediately prior to use. Prolonged storage, even at -20°C, may result in reduced potency due to hydrolysis or oxidation.
• Cytotoxicity: Ensure DMSO concentration in cell culture does not exceed 0.1% v/v. Run vehicle controls to distinguish compound-specific effects.
• Off-target Effects: Dorsomorphin is highly selective for AMPK but can inhibit BMP/Smad signaling at lower concentrations. Titrate dosages and confirm pathway inhibition with pathway-specific readouts (e.g., p-ACC for AMPK, p-Smad1/5/8 for BMP).
• Batch Variability: Always validate new lots with a reference assay (e.g., AMPK activity or SMAD phosphorylation) to ensure consistency.
• Interpreting Negative Results: If expected inhibition is not observed, validate compound uptake by cells, confirm with Western blot or immunofluorescence, and verify the functionality of downstream signaling components.

For advanced troubleshooting and optimization, the article "Dorsomorphin (Compound C): Precision AMPK and BMP Inhibition in Muscle Research" offers practical extension strategies, particularly in mitochondrial quality control and skeletal muscle metabolism.

Future Outlook: Expanding the Impact of Dorsomorphin in Translational Science

As disease models grow in complexity, the demand for precise modulators like Dorsomorphin (Compound C) intensifies. Its dual inhibition of AMPK and BMP/Smad signaling is unlocking new frontiers in metabolic syndrome, cancer research, autophagy regulation, and neural stem cell differentiation. Emerging evidence from studies like Ren et al. (2025) underscores the centrality of the AMPK/PINK1/Parkin axis in muscle atrophy, highlighting Dorsomorphin’s critical role in validating pathway dependencies and therapeutic targets.

Looking ahead, the integration of Dorsomorphin into high-throughput screening, combinatorial drug testing, and next-generation animal models will further accelerate discovery. Its unique selectivity profile and robust in vivo efficacy make it a foundation for mechanistic studies and a potential adjunct in preclinical therapeutic development.

For a deep-dive analysis on application-specific strategies and future directions, refer to "Dorsomorphin (Compound C): Advanced Insights into AMPK and BMP Modulation", which complements this overview by exploring emergent research trends and methodological innovations.

Conclusion

Dorsomorphin (Compound C) is more than a pathway inhibitor—it is a precision tool for dissecting the interplay between metabolism, autophagy, and cellular differentiation. By enabling targeted manipulation of the AMPK and BMP/Smad axes, Dorsomorphin equips researchers with the flexibility and rigor required for advanced translational research. Whether in metabolic disease, cancer, or neural development models, its data-driven performance and optimization potential make it an enduring asset for the scientific community.